window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 28, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Advanced Therapies

  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Lonza’s Synaffix and Sidewinder enter multi-target license agreement for bispecific ADCs

    Synaffix B.V., a Lonza company focused on clinical-stage antibody-drug conjugate [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Manufacturing & Supply Chain

    FUJIFILM Biosciences unveils new name and broad life sciences focus

    FUJIFILM Irvine Scientific has officially rebranded as FUJIFILM Biosciences, signalling [...]

    May 5, 2026
  • Advanced Therapies,Pharmaceuticals and therapeutics,Therapeutic Areas

    Grifols fibrinogen concentrate FESILTY approved in the US for acute bleeding in congenital fibrinogen deficiency

    Grifols has received US Food and Drug Administration (FDA) approval [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Manufacturing & Supply Chain

    eXmoor and UCL partner to accelerate academic cell and gene therapy programmes

    eXmoor Pharma has formed a strategic collaboration with University College [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Opinion & Events,Pharmaceuticals and therapeutics,Therapeutic Areas

    CytoAgents to present new CTO1681 clinical safety data at ASH annual meeting

    CytoAgents will present new clinical safety data for CTO1681 at [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Therapeutic Areas

    EMA grants orphan drug designation to Kedrion treatment for congenital aceruloplasminemia

    Kedrion has received orphan drug designation from the European Medicines [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Flagship Pioneering signs new agreements with ProFound Therapeutics and Quotient Therapeutics with GSK collaboration

    Flagship Pioneering has announced that ProFound Therapeutics and Quotient Therapeutics [...]

    May 5, 2026
  • Advanced Therapies,Manufacturing & Supply Chain

    University of Chicago team completes first automated 3-in-1 TCR-T manufacturing run on Quantum Flex bioreactor

    Terumo Blood and Cell Technologies has reported what it described [...]

    May 5, 2026
  • Advanced Therapies,Drug Discovery & Development,Opinion & Events,Therapeutic Areas

    Terumo BCT and Santersus partner to advance therapeutic apheresis for sepsis treatment

    Terumo Blood and Cell Technologies (Terumo BCT) and Santersus AG [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Cytovance Biologics celebrates 20 years advancing biopharma manufacturing in Oklahoma City

    Cytovance Biologics, a contract development and manufacturing organisation serving the [...]

    May 5, 2026
Previous8910Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • OrganaBio expands European access to perinatal and blood-derived research materials through Bio-Connect partnership
    Categories: Advanced Therapies, Biotech & Pharma Business
  • Single use support launches next-generation controlled-rate blast freezer
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain
  • Bio-Europe unveils renewed vision as global biopharma strategy forum
    Categories: Biotech & Pharma Business, Opinion & Events
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top